KIMBERLY BRINCKERHOFF: Open Payments
NPI 1730774944 · WEST HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 15 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $122 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
Products named: FANAPT, REXULTI, Qelbree, CAPLYTA, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
